Liquidia Corp

NASDAQ:LQDA  
3.20
-0.06 (-1.84%)
Products

Liquidia Receives Favorable Ruling In Inter Partes Review Against United Therapeutics Patent

Published: 10/08/2021 21:37 GMT
Liquidia Corp (LQDA) - Liquidia Receives Favorable Ruling in Inter Partes Review Against United Therapeutics Patent.
Liquidia Corp - in Its Ruling, Ptab Found That Seven of Nine Claims Were Unpatentable.
Liquidia Corp - Ptab's Decision With Respect to '901 Patent Does Not Resolve On-going Litigation Brought by Utc Related to Liq861.